electroCore (ECOR) Long-Term Deferred Tax (2018)

electroCore's (ECOR) quarterly Long-Term Deferred Tax came in at $24.6 million in Q4 2018.

electroCore (ECOR) Long-Term Deferred Tax (2018) Analysis & Trends

electroCore's Long-Term Deferred Tax history runs 1 years deep, the most recent figure standing at $24.6 million for Q4 2018.

On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $24.6 million in Q4 2018; TTM through Dec 2018 was $24.6 million, a N/A change from a year earlier, with the FY2018 full-year figure at $24.6 million, changed N/A from the prior year.
Long-Term Deferred Tax steadied at $24.6 million in Q4 2018 per ECOR's latest filing.
Across five years, Long-Term Deferred Tax topped out at $24.6 million in Q4 2018 and bottomed at $24.6 million in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	electroCore	56,941.08	-8.77 Mn	8.36 Mn

Download Data

Date	Value
Dec 31, 2018	24.58 Mn